Timothy A. Springer, Ph.D.
Founder; Board of Directors; Co-chair, Scientific Advisory Board
Timothy A Springer, Ph.D. is the Latham Family Professor at Harvard Medical School and Boston Children’s Hospital. He is a world leader in structural biology and immunology. He is also a founder and private investor in biopharmaceutical ventures including LeukoSite, Scholar Rock, Morphic Therapeutic, Moderna Therapeutic, Editas Medicine, Selecta Biosciences, and Ab Initio Biotherapeutics. His research and company formation has led to six FDA-approved drugs, including antibodies for treating cancer and immune diseases.